{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:59:31Z","timestamp":1788184771177,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"publisher","award":["CTM2009CTM2012-38720-C03-01"],"award-info":[{"award-number":["CTM2009CTM2012-38720-C03-01"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002847","name":"Ministerio de Educaci\u00f3n for a predoctoral scholarship","doi-asserted-by":"publisher","award":["AP2010-4278"],"award-info":[{"award-number":["AP2010-4278"]}],"id":[{"id":"10.13039\/501100002847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jpba.2014.10.010","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T02:15:20Z","timestamp":1418436920000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"special_numbering":"C","title":["Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease"],"prefix":"10.1016","volume":"107","author":[{"given":"Ra\u00fal","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Garc\u00eda-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"G\u00f3mez-Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.10.010_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/14737159.4.2.189","article-title":"Metabonomics and its role in drug development and disease diagnosis","volume":"4","author":"Lindon","year":"2004","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jpba.2014.10.010_bib0010","series-title":"Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis","article-title":"The human metabolome","author":"Beecher","year":"2003"},{"key":"10.1016\/j.jpba.2014.10.010_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jpba.2014.10.010_bib0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cbpa.2003.08.008","article-title":"Metabonomics NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis","volume":"7","author":"Griffin","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1039\/b602376m","article-title":"Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy","volume":"131","author":"Ellis","year":"2006","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2014.10.010_bib0030","doi-asserted-by":"crossref","first-page":"011001","DOI":"10.1088\/1478-3975\/5\/1\/011001","article-title":"Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes","volume":"5","author":"Dunn","year":"2008","journal-title":"Phys. Biol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0035","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/81137","article-title":"Metabolite profiling for plant functional genomics","volume":"18","author":"Fiehn","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jchromb.2008.04.033","article-title":"Gas chromatography\/mass spectrometry in metabolic profiling of biological fluids","volume":"871","author":"Pasikanti","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.10.010_bib0045","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11306-010-0254-3","article-title":"Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectives","volume":"7","author":"Koek","year":"2011","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jbiotec.2005.12.012","article-title":"Current challenges and developments in GC\u2013MS based metabolite profiling technology","volume":"124","author":"Kopka","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11306-008-0111-9","article-title":"Metabolomic analysis of urine and serum in Parkinson's disease","volume":"4","author":"Michell","year":"2008","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s11306-010-0224-9","article-title":"Serum metabolomics as a novel diagnostic approach for pancreatic cancer","volume":"6","author":"Nishiumi","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lungcan.2011.02.008","article-title":"A metabolomic approach to lung cancer","volume":"74","author":"Hori","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jpba.2014.10.010_bib0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11306-011-0278-3","article-title":"Serum metabolite signature predicts the acute onset of diabetes in spontaneously diabetic congenic BB rats","volume":"7","author":"Akesson","year":"2011","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jpba.2014.10.010_bib0080","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer's disease cerebrospinal fluid","volume":"7","author":"Czech","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jpba.2014.10.010_bib0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKahnn","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jpba.2014.10.010_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF01318865","article-title":"Free d- and l-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects","volume":"15","author":"Fisher","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpba.2014.10.010_bib0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11064-009-0087-5","article-title":"Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease","volume":"35","author":"Fraser","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jpba.2014.10.010_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2014.10.010_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease","volume":"104","author":"Gonzalez-Dominguez","year":"2014","journal-title":"J. Proteomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0110","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1021\/ac9011599","article-title":"Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum","volume":"81","author":"Begley","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2014.10.010_bib0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chroma.2007.04.021","article-title":"Data processing for mass spectrometry-based metabolomics","volume":"1158","author":"Katajamaa","year":"2007","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2014.10.010_bib0120","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2014.10.010_bib0125","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/ac201065j","article-title":"Optimized preprocessing of ultra-performance liquid chromatography\/mass spectrometry urinary metabolic profiles for improved information recovery","volume":"83","author":"Veselkov","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2014.10.010_bib0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data","volume":"7","author":"van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0135","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/bioinformatics\/btq418","article-title":"MetPA: a web-based metabolomics tool for pathway analysis and visualization","volume":"26","author":"Xia","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpba.2014.10.010_bib0140","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.talanta.2014.07.075","article-title":"Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer's disease","volume":"131","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2015","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2014.10.010_bib0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jpba.2014.10.010_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-3940(95)12058-C","article-title":"Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease","volume":"199","author":"Parnetti","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2014.10.010_bib0155","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pnpbp.2010.07.004","article-title":"Mitochondrial dysfunction and Alzheimer's disease","volume":"35","author":"Maruszak","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ana.20474","article-title":"Mitochondrial abnormalities in Alzheimer brain: mechanistic implications","volume":"57","author":"Bubber","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000022031","article-title":"Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients","volume":"44","author":"Redjems-Bennani","year":"1998","journal-title":"Gerontology"},{"key":"10.1016\/j.jpba.2014.10.010_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects","volume":"32","author":"Fonteh","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.jpba.2014.10.010_bib0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0197-4580(84)90009-5","article-title":"A preliminary study of free amino acids in the postmorten temporal cortex from Alzheimer-type dementia patients","volume":"5","author":"Arai","year":"1984","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpba.2014.10.010_bib0180","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s007020050058","article-title":"Abnormal amino acid metabolism in patients with early stage Alzheimer dementia","volume":"105","author":"Fekkes","year":"1998","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jpba.2014.10.010_bib0185","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.bbamem.2010.12.001","article-title":"Adenosine receptors and brain diseases: neuroprotection and neurodegeneration","volume":"1808","author":"Gomes","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpba.2014.10.010_bib0190","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up-regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1750-3639.2003.tb00475.x","article-title":"A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer's disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation","volume":"13","author":"Angulo","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.brainresbull.2009.10.010","article-title":"Gender- and age-dependent changes in nucleoside levels in the cerebral cortex and white matter of the human brain","volume":"81","author":"Kov\u00e1cs","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jpba.2014.10.010_bib0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.jpba.2014.10.010_bib0210","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1046\/j.1471-4159.1996.66041592.x","article-title":"Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease: correlations with depression and neuroleptic medication","volume":"66","author":"Chen","year":"1996","journal-title":"Neurochemistry"},{"key":"10.1016\/j.jpba.2014.10.010_bib0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s007020050029","article-title":"Tryptophan degradation and immune activation in Alzheimer's disease","volume":"107","author":"Widner","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jpba.2014.10.010_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(92)90322-X","article-title":"Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia","volume":"141","author":"Tohgi","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2014.10.010_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10334-003-0004-x","article-title":"Reduced glutamate neurotransmission in patients with Alzheimer's disease \u2013 an in vivo 13C magnetic resonance spectroscopy study","volume":"16","author":"Lin","year":"2003","journal-title":"MAGMA"},{"key":"10.1016\/j.jpba.2014.10.010_bib0230","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3945\/ajcn.2008.27037","article-title":"Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk","volume":"90","author":"Devore","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jpba.2014.10.010_bib0235","first-page":"2181","article-title":"Free fatty acids stimulate the polymerization of tau and amyloid \u03b2 peptides","volume":"150","author":"Wilson","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0240","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neurobiolaging.2010.09.013","article-title":"Serum fatty acid profiles using GC\u2013MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease","volume":"33","author":"Wang","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpba.2014.10.010_bib0245","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease","volume":"29","author":"Cunnane","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpba.2014.10.010_bib0250","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpba.2014.10.010_bib0255","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.jpba.2014.10.010_bib0260","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/clinchem\/25.7.1343","article-title":"Proposed mechanism for urea nitrogen re-utilization: relationship between urea and proposed guanidine cycles","volume":"25","author":"Natelson","year":"1979","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2014.10.010_bib0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0301-0082(02)00019-9","article-title":"Neurobiology of ammonia","volume":"67","author":"Felipo","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpba.2014.10.010_bib0270","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3233\/JAD-2010-100630","article-title":"Is the urea cycle involved in Alzheimer's disease?","volume":"21","author":"Hansmannel","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jpba.2014.10.010_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0304-3940(95)11301-C","article-title":"Increased immunostaining for l-ornithine decarboxylase occurs in neocortical neurons of Alzheimers-disease patients","volume":"186","author":"Bernstein","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jpba.2014.10.010_bib0280","doi-asserted-by":"crossref","first-page":"19129","DOI":"10.1074\/jbc.271.32.19129","article-title":"Role of oxoproline in the regulation of neutral amino acid transport across the blood\u2013brain barrier","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2014.10.010_bib0285","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/j.febslet.2006.06.097","article-title":"Pyroglutamate stimulates Na+-dependent glutamate transport across the blood\u2013brain barrier","volume":"580","author":"Hawkins","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jpba.2014.10.010_bib0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brainres.2006.03.063","article-title":"Age-related changes in glutathione and glutathione-related enzymes in rat brain","volume":"1090","author":"Zhu","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.jpba.2014.10.010_bib0295","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neurobiolaging.2004.10.002","article-title":"Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases","volume":"26","author":"Migliore","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jpba.2014.10.010_bib0300","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer's disease","volume":"21","author":"Kim","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jpba.2014.10.010_bib0305","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jn\/134.3.489","article-title":"Glutathione metabolism and its implications for health","volume":"134","author":"Wu","year":"2004","journal-title":"J. Nutr."},{"key":"10.1016\/j.jpba.2014.10.010_bib0310","doi-asserted-by":"crossref","first-page":"e12538","DOI":"10.1371\/journal.pone.0012538","article-title":"Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease","volume":"5","author":"Astarita","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jpba.2014.10.010_bib0315","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1194\/jlr.P700023-JLR200","article-title":"Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia","volume":"48","author":"Goodenowe","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jpba.2014.10.010_bib0320","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/108.7.1200","article-title":"The neurotoxicity of valine deficiency in rats","volume":"108","author":"Cusick","year":"1978","journal-title":"J. Nutr."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514005019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708514005019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T22:13:44Z","timestamp":1598566424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708514005019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":64,"alternative-id":["S0731708514005019"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.10.010","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}